Published December 2020
| Version v1
Journal article
High prevalence for obesity in severe COVID-19: Possible links and perspectives towards patient stratification
Contributors
Others:
- UMRS 1269 INSERM/Sorbonne University, Nutriomics, Faculte de medecine Pitie-Salp^etriere, F-75013, Paris
- Université Côte d'Azur, CNRS, INSERM, Institute of Biology Valrose (iBV), Parc Valrose, Nice, FRANCE.
- Centre National de la Recherche Scientifique, Universite de Strasbourg, Institut des Neurosciences Cellulaires et Integratives, F-67000, Strasbourg
- ANR-19-CE44-0019,PA-Box,Etude des fonctions pléiotropiques de l'acide phosphatidique dans la sécrétion régulée à l'aide d'une nouvelle boite à outils moléculaires(2019)
Description
It is becoming obvious that in addition to aging and various hearth pathologies, excess of body weight, especially obesity is a major risk factor for severity of COVID-19 infection. Intriguingly the receptor for SARS-CoV-2 is ACE2, a member of the angiotensin receptor family that has a relatively large tissue distribution. This observation likely explains the multitude of symptoms that have been described from human patients. The adipose tissue also expresses ACE2, suggesting that adipocytes are potentially infected by SARS-CoV-2. Here we discuss some of the potential contribution of the adipose tissue to the severity of the infection and propose some aspects of obese patients metabolic phenotyping to help stratification of individuals with high risk of severe disease.
Abstract
International audienceAdditional details
Identifiers
- URL
- https://hal.science/hal-04492081
- URN
- urn:oai:HAL:hal-04492081v1
Origin repository
- Origin repository
- UNICA